Claire Fraser's Net Worth
$6.76 Million
Who is Claire Fraser?
Claire Fraser has an estimated net worth of $6.76 Million. This is based on reported shares across multiple companies, which include BECTON DICKINSON & CO, Seres Therapeutics, Inc., and HELICOS BIOSCIENCES CORP.
SEC CIK
Claire Fraser's CIK is 0001382031
Past Insider Trading and Trends
2023 was Claire Fraser's most active year for acquiring shares with 3 total transactions. Claire Fraser's most active month to acquire stocks was the month of December. 2020 was Claire Fraser's most active year for disposing of shares, totalling 3 transactions. Claire Fraser's most active month to dispose stocks was the month of January. 2023 saw Claire Fraser paying a total of $0.00 for 83,848 shares, this is the most they've acquired in one year. In 2019 Claire Fraser cashed out on 1,429 shares for a total of $347,618.54, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BECTON DICKINSON & CO (BDX) Snapshot price: $239.24
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.13% | 900 |
—
|
—
| 22.7K |
Jan 23
| |||
Form 4
| -3.78% | -848.00 |
$281.66 | -$238,847.68 | 21.61K |
Aug 28
| |||
Form 4
| +3.95% | 848 |
—
|
—
| 22.31K |
Jan 26
| |||
Form 4
| -3.75% | -841.00 |
$271.70 | -$228,499.70 | 21.56K |
Feb 8
| |||
Form 4
| +3.80% | 820 |
—
|
—
| 22.4K |
Jan 25
| |||
Form 4
| -1.88% | -387.00 |
$251.58 | -$97,361.46 | 20.22K |
Aug 18
| |||
Form 4
| -1.86% | -390.00 |
$241.36 | -$94,130.40 | 20.61K |
May 27
| |||
Form 4
| +4.11% | 829 |
—
|
—
| 21K |
Jan 26
| |||
Form 4
| -3.68% | -771.00 |
$256.56 | -$197,807.76 | 20.17K |
May 8
| |||
Form 4
| -6.68% | -1.50K |
$258.72 | -$388,074.00 | 20.94K |
Feb 11
| |||
Form 4
| +3.53% | 765 |
—
|
—
| 22.44K |
Jan 28
| |||
Form 4
| -6.22% | -1.43K |
$243.26 | -$347,618.54 | 21.54K |
Aug 7
| |||
Form 4
| +4.21% | 923 |
—
|
—
| 22.84K |
Jan 22
| |||
Form 4
| +4.55% | 941 |
—
|
—
| 21.64K |
Jan 23
| |||
Form 4
| +6.15% | 1.18K |
—
|
—
| 20.39K |
Jan 24
| |||
Form 4
| +7.31% | 1.27K |
—
|
—
| 18.6K |
Jan 26
| |||
Form 4
| +8.41% | 1.34K |
—
|
—
| 17.33K |
Jan 27
| |||
Form 4
| +11.33% | 1.6K |
—
|
—
| 15.7K |
Jan 28
| |||
Form 4
| +17.10% | 2.01K |
—
|
—
| 13.75K |
Jan 29
| |||
Form 4
| +22.81% | 2.13K |
—
|
—
| 11.48K |
Jan 31
| |||
Form 4
| +24.28% | 1.8K |
—
|
—
| 9.2K |
Feb 1
| |||
Form 4
| +36.97% | 1.95K |
—
|
—
| 7.24K |
Feb 2
| |||
Form 4
| +62.52% | 2K |
—
|
—
| 5.21K |
Feb 3
| |||
Form 4
| +99.62% | 1.57K |
—
|
—
| 3.16K |
Jan 29
| |||
Form 4
|
∞
| 1.56K |
—
|
—
| 1.56K |
Jan 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Seres Therapeutics, Inc. (MCRB) Snapshot price: $1.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HELICOS BIOSCIENCES CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||